ESH/LinkedIn
Apr 27, 2026, 15:38
Key Insights from ESHMPN 26 on Advances in MPN Management – ESH
The European School of Haematology (ESH) shared a post on LinkedIn:
“Today’s second ESHMPN 26 session chaired by Jean – Jacques Kiladjian (INSERM) focussed on MPN management.
Marta Sobas (Collegium Medicum Uniwersytetu Mikołaja Kopernika) on the role of interferons on haematological and molecular responses;
- Jennifer O’Sullivan (Guy’s and St Thomas’ NHS Foundation Trust) on new potential trial endpoints;
- Chloé James (CHU de Bordeaux) on how to prevent thrombosis and bleeding in MPN;
- Selected brief oral presentation by Chiara Carretta, (Centro di Medicina Estetica e Rigenerativa) on determinants of JAK inhibitor efficacy in myelofibrosis revealed by Multiomic Single-Cell Analysis
Stay tuned!
For a deeper insight, meet Marta Sobas, Jennifer O’Sullivan, or Chloé James at tomorrow’s meeting the expert session!”
Stay updated with Hemostasis Today.
-
Apr 27, 2026, 15:30Shahid Gilani: Risk of Thrombosis in Central Venous Catheters in Cancer Patients
-
Apr 27, 2026, 15:24Anirban Sen Gupta: PlateChek Microsensor for Rapid Coagulation Testing
-
Apr 27, 2026, 15:04Tareq Abadl։ Why You Should Never Separate Serum Before Clotting Is Complete
-
Apr 27, 2026, 14:55Diana Domenica Bruno։ Flying During Pregnancy and Clinical Considerations
-
Apr 27, 2026, 14:46Mariam Swidan: Hemolytic Anemia – Disease Overview
-
Apr 27, 2026, 14:39Talha Aman: How CABG Works to Restore Blood Flow to the Heart
-
Apr 27, 2026, 14:38Olivia Romero Lux: Raising Awareness of Bleeding Disorders in Women
-
Apr 27, 2026, 14:37Mansi Kala: Improving Patient Care in Hematological Disorders Through Diagnostic Challenges Research at ISTH 2026
-
Apr 27, 2026, 14:35Sara Moscatelli: Apixaban in Children is Not Just Safe, But Biologically Active